Deutsche Bank’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $842K | Sell |
226,939
-9,218
| -4% | -$34.2K | ﹤0.01% | 2185 |
|
|
2025
Q1 | $763K | Sell |
236,157
-5,696
| -2% | -$18.4K | ﹤0.01% | 2265 |
|
|
2024
Q4 | $1.35M | Sell |
241,853
-560,784
| -70% | -$3.12M | ﹤0.01% | 2057 |
|
|
2024
Q3 | $8.68M | Buy |
802,637
+678,298
| +546% | +$7.33M | ﹤0.01% | 1054 |
|
|
2024
Q2 | $2.61M | Buy |
124,339
+2,479
| +2% | +$52K | ﹤0.01% | 1501 |
|
|
2024
Q1 | $3.88M | Sell |
121,860
-365,133
| -75% | -$11.6M | ﹤0.01% | 1353 |
|
|
2023
Q4 | $9.87M | Buy |
486,993
+471,424
| +3,028% | +$9.55M | 0.01% | 999 |
|
|
2023
Q3 | $198K | Sell |
15,569
-660,584
| -98% | -$8.41M | ﹤0.01% | 2767 |
|
|
2023
Q2 | $12.2M | Buy |
676,153
+595,886
| +742% | +$10.8M | 0.01% | 915 |
|
|
2023
Q1 | $1.38M | Buy |
80,267
+5,298
| +7% | +$91.1K | ﹤0.01% | 1900 |
|
|
2022
Q4 | $1.67M | Buy |
74,969
+1,649
| +2% | +$36.6K | ﹤0.01% | 1756 |
|
|
2022
Q3 | $589K | Buy |
73,320
+60,027
| +452% | +$482K | ﹤0.01% | 2280 |
|
|
2022
Q2 | $93K | Sell |
13,293
-2,226
| -14% | -$15.6K | ﹤0.01% | 3525 |
|
|
2022
Q1 | $235K | Sell |
15,519
-1,764
| -10% | -$26.7K | ﹤0.01% | 3151 |
|
|
2021
Q4 | $379K | Buy |
17,283
+422
| +3% | +$9.25K | ﹤0.01% | 2986 |
|
|
2021
Q3 | $454K | Buy |
16,861
+6,220
| +58% | +$167K | ﹤0.01% | 3087 |
|
|
2021
Q2 | $257K | Buy |
10,641
+930
| +10% | +$22.5K | ﹤0.01% | 3607 |
|
|
2021
Q1 | $422K | Buy |
+9,711
| New | +$422K | ﹤0.01% | 3194 |
|